» Articles » PMID: 27136900

Application of Rapid in Vitro Co-culture System of Macrophages and T-cell Subsets to Assess the Immunogenicity of Dogs Vaccinated with Live Attenuated Leishmania Donovani Centrin Deleted Parasites (LdCen-/-)

Abstract

Background: Live attenuated Leishmania donovani parasites as LdCen(-/-) were shown to confer protective immunity against Leishmania infection in mice, hamsters, and dogs. Strong immunogenicity in dogs vaccinated with LdCen(-/-) has been previously reported, including increased antibody response favoring Th1 response lymphoproliferative responses, CD4(+) and CD8(+) T-cells activation, increased levels of Th1 and reduction of Th2 cytokines, in addition to a significant reduction in parasite burden after 18 and 24 months post virulent parasite challenge.

Methods: Aimed at validating a new method using in vitro co-culture systems with macrophages and purified CD4(+) or CD8(+) or CD4(+):CD8(+) T-cells of immunized dogs with both LdCen(-/-) and Leishmune® to assess microbicide capacity of macrophages and the immune response profile as the production of IFN-γ, TNF-α, IL-12, IL-4 and IL-10 cytokines.

Results And Discussion: Our data showed co-cultures of macrophages and purified T-cells from dogs immunized with LdCen(-/-) and challenged with L. infantum were able to identify high microbicidal activity, especially in the co-culture using CD4(+) T-cells, as compared to the Leishmune® group. Similarly, co-cultures with CD8(+) T-cells or CD4(+):CD8(+) T-cells in both experimental groups were able to detect a reduction in the parasite burden in L. infantum infected macrophages. Moreover, co-cultures using CD4(+) or CD8(+) or CD4(+):CD8(+) T-cells from immunized dogs with both LdCen(-/-) and Leishmune® were able to identify higher levels of IFN-γ and IL-12 cytokines, reduced levels of IL-4 and IL-10, and a higher IFN-γ/IL-10 ratio. While the highest IFN-γ levels and IFN-γ/IL-10 ratio were the hallmarks of LdCen(-/-) group in the co-culture using CD4(+) T-cells, resulting in strong reduction of parasitism, the Leishmune® immunization presented a differential production of TNF-α in the co-culture using CD4(+):CD8(+) T-cells.

Conclusion: The distinct conditions of co-culture systems were validated and able to detect the induction of immune protection. The method described in this study applied a new, more accurate approach and was able to yield laboratory parameters useful to test and monitor the immunogenicity and efficacy of Leishmania vaccines in dogs.

Citing Articles

The History of Live Attenuated Gene-Deleted Vaccine Candidates.

Volpedo G, Bhattacharya P, Gannavaram S, Pacheco-Fernandez T, Oljuskin T, Dey R Pathogens. 2022; 11(4).

PMID: 35456106 PMC: 9025045. DOI: 10.3390/pathogens11040431.


Advancements in Assessments of Bio-Tissue Engineering and Viable Cell Delivery Matrices Using Bile Acid-Based Pharmacological Biotechnologies.

Mooranian A, Jones M, Ionescu C, Walker D, Wagle S, Kovacevic B Nanomaterials (Basel). 2021; 11(7).

PMID: 34361247 PMC: 8308343. DOI: 10.3390/nano11071861.


Expression analysis of centrin gene in promastigote and amastigote forms of leishmania infantum iranian isolates: a promising target for live attenuated vaccine development against canine leishmaniasis.

Abbaszadeh Afshar M, Elikaee S, Saberi R, Mohtasebi S, Mohebali M BMC Vet Res. 2021; 17(1):162.

PMID: 33853591 PMC: 8045990. DOI: 10.1186/s12917-021-02816-x.


Vaccines Entered in Clinical Trials: A Review of Literature.

Moafi M, Rezvan H, Sherkat R, Taleban R Int J Prev Med. 2019; 10:95.

PMID: 31360342 PMC: 6592111. DOI: 10.4103/ijpvm.IJPVM_116_18.

References
1.
Giunchetti R, Reis A, da Silveira-Lemos D, Martins-Filho O, Correa-Oliveira R, Bethony J . Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis. Res Vet Sci. 2007; 85(1):106-12. DOI: 10.1016/j.rvsc.2007.09.008. View

2.
Araujo M, de Andrade R, Sathler-Avelar R, Teixeira-Carvalho A, Andrade M, Vianna L . T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune. Vaccine. 2008; 27(7):1008-17. DOI: 10.1016/j.vaccine.2008.11.104. View

3.
Lemesre J, Holzmuller P, Goncalves R, Bourdoiseau G, Hugnet C, Cavaleyra M . Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Vaccine. 2007; 25(21):4223-34. DOI: 10.1016/j.vaccine.2007.02.083. View

4.
Holzmuller P, Cavaleyra M, Moreaux J, Kovacic R, Vincendeau P, Papierok G . Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis. Vet Immunol Immunopathol. 2005; 106(3-4):247-57. DOI: 10.1016/j.vetimm.2005.03.001. View

5.
DEANE L, DEANE M . Visceral leishmaniasis in Brazil: geographical distribution and trnsmission. Rev Inst Med Trop Sao Paulo. 1962; 4:198-212. View